Cargando…

1139. Novel Formulation SUBA-Itraconazole Prophylaxis in Patients With Hematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation: Follow-up Survival Data

BACKGROUND: Despite the advantageous spectrum of activity of itraconazole, it is rarely used as a prophylactic agent due to limited bioavailability and intolerance of the conventional formulation. After the development of a novel formulation SUBA-itraconazole® (SUper BioAvailability), we undertook a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindsay, Julian, Sandaradura, Indy, Wong, Kelly, Arthur, Chris, Stevenson, William, Kerridge, Ian, Fay, Keith, Coyle, Luke, Greenwood, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255503/ http://dx.doi.org/10.1093/ofid/ofy210.972

Ejemplares similares

SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
por: Lindsay, Julian, et al.
Publicado: (2021)

1354. Novel Formulation SUBA-Itraconazole in Fed and Fasted Healthy Volunteers: Expanding the Clinical Utility of the Established Mold Active Agent
por: Lindsay, Julian, et al.
Publicado: (2018)

120. An open-label comparative trial of SUBA-itraconazole (SUBA) versus conventional itraconazole (c-itra) for treatment of proven and probable endemic mycoses (MSG-15): a pharmacokinetic (PK) and adverse Event (AE) analysis
por: Pappas, Peter G, et al.
Publicado: (2021)

144. MSG-15: Pharmacokinetic (PK), Adverse Events (AEs), and Tolerability Data from an Open Label Randomized Clinical Trial (RCT) Comparing Oral Suba-itraconazole (SUBA-ITC) to Conventional Itraconazole (C-ITC) for Treatment of Endemic Mycosis (EM)
por: Pappas, Peter G, et al.
Publicado: (2020)

SUBA: the Arabidopsis Subcellular Database
por: Heazlewood, Joshua L., et al.
Publicado: (2007)

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
por: Marks, David I, et al.
Publicado: (2011)

Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison for a 3-Day Loading Dose Regimen and 15-Day Steady-State Administration of SUBA-Itraconazole and Conventional Itraconazole Capsules in Healthy Adults
por: Thompson, George R., et al.
Publicado: (2020)

2229. Relative Bioavailability of a Single Oral Dose of SUBA-Itraconazole 65 mg Capsule Compared with Conventional Itraconazole 100 mg Capsule Administered Under Fasted and Fed Conditions in Healthy Adult Volunteers
por: Mudge, Stuart, et al.
Publicado: (2019)

Novel Aspects of the SubA Subunit of the Subtilase Cytotoxin
por: Sessler, Katharina, et al.
Publicado: (2022)

Management of thoracic trauma in emergency service: Analysis of 1139 cases
por: Dongel, Isa, et al.
Publicado: (2013)

Draft Genome Sequence of Subantarctic Rhodococcus sp. Strain 1139
por: Nahar, Akhikun, et al.
Publicado: (2017)

Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation
por: Döring, M., et al.
Publicado: (2013)

Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation
por: Jansen, Anouk M E, et al.
Publicado: (2023)

Characteristics of Skin Deposition of Itraconazole Solubilized in Cream Formulation
por: Kim, Hyeongmin, et al.
Publicado: (2019)

Spatial distribution of African Animal Trypanosomiasis in Suba and Teso districts in Western Kenya
por: Thumbi, Samuel M, et al.
Publicado: (2010)

SUBA4: the interactive data analysis centre for Arabidopsis subcellular protein locations
por: Hooper, Cornelia M., et al.
Publicado: (2017)

Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation
por: Nakarani, M., et al.
Publicado: (2010)

Cambridge Breast Intensity Modulated Radiotherapy Trial: dosimetry results for 1,139 patients
por: Coles, CE, et al.
Publicado: (2008)

1139. Adherence to Zika virus-related Pediatric Follow-up Care in Puerto Rico
por: Levison, Julie H, et al.
Publicado: (2020)

Draft Genome Sequence of Lactiplantibacillus plantarum NMZ-1139, Isolated from Whisky Mash
por: Takagi, Hiroshi, et al.
Publicado: (2021)

Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia
por: Döring, M., et al.
Publicado: (2015)

Targeting the Unfolded Protein Response in Glioblastoma Cells with the Fusion Protein EGF-SubA
por: Prabhu, Antony, et al.
Publicado: (2012)

Knee Pathology before and after SARS-CoV-2 Pandemic: An Analysis of 1139 Patients
por: Giorgino, Riccardo, et al.
Publicado: (2021)

1139. Reducing Collection of Tracheal Aspirate Bacterial Cultures: A Diagnostic Test Stewardship Intervention
por: Chiotos, Kathleen, et al.
Publicado: (2021)

Formulation and delivery of itraconazole to the brain using a nanolipid carrier system
por: Lim, Wei Meng, et al.
Publicado: (2014)

Study on Formulation, in vivo Exposure, and Passive Targeting of Intravenous Itraconazole Nanosuspensions
por: Yuan, Qi, et al.
Publicado: (2019)

SUBA3: a database for integrating experimentation and prediction to define the SUBcellular location of proteins in Arabidopsis
por: Tanz, Sandra K., et al.
Publicado: (2013)

2696. Breakthrough Toxoplasmosis While on Atovaquone Prophylaxis Following Allogeneic Hematologic Stem Cell Transplantation
por: Chueng, Teresa A, et al.
Publicado: (2019)

Patient-level cost of home- and facility-based child pneumonia treatment in Suba Sub County, Kenya
por: Machuki, Joel Amenya, et al.
Publicado: (2019)

Bioequivalence of Orally Administered Generic, Compounded, and Innovator‐Formulated Itraconazole in Healthy Dogs
por: Mawby, D.I., et al.
Publicado: (2013)

Production of Itraconazole Nanocrystal-Based Polymeric Film Formulations for Immediate Drug Release
por: Karagianni, Anna, et al.
Publicado: (2020)

Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis
por: Yang, Xue, et al.
Publicado: (2021)

In vitro and in vivo assessment of hydroxypropyl cellulose as functional additive for enabling formulations containing itraconazole
por: Bachmaier, Rafael D., et al.
Publicado: (2021)

1139. Multidisciplinary Initiative to Increase Guideline-Concordant Antibiotic Prescriptions at Discharge for Hospitalized Children with Uncomplicated Community-Acquired Pneumonia
por: Yonts, Alexandra B, et al.
Publicado: (2019)

1139. Oral Antivirals Against SARS-CoV-2: a New Valid Strategy Against COVID-19
por: Braccialarghe, Neva, et al.
Publicado: (2022)

Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design
por: Gajra, Balaram, et al.
Publicado: (2015)

Pharmacokinetics and Relative Bioavailability of Orally Administered Innovator‐Formulated Itraconazole Capsules and Solution in Healthy Dogs
por: Hasbach, A.E., et al.
Publicado: (2017)

Design of Novel Nanoemulsion Formulations for Topical Ocular Delivery of Itraconazole: Development, Characterization and In Vitro Bioassay
por: Mehrandish, Saba, et al.
Publicado: (2022)

Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome
por: Shen, Yandong, et al.
Publicado: (2021)

P1139: A POPULATION-BASED STUDY OF ISOLATED ADULT PULMONARY LANGERHANS CELL HISTIOCYTOSIS IN THE UNITED STATES: 2010-2017
por: Ruan, G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_46ukh40diugq9dn90m32jjajsg